Cash Flow Statement (Annual)
CAA / CalAtlantic Group, Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.
All numbers are times 1,000 except per share units.
|Net Cash Provided By Used In Operating Activities|
|Net Income Loss||-13,786||-11,724||-16,417||531,421||188,715||215,865||213,509||484,730|
|Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities|
|Income Loss From Equity Method Investments||-4,598||1,166||207||-2,090||949||-668||1,966||4,057|
|Depreciation Depletion And Amortization||3,516||3,002||3,255||2,480||3,576||4,928||41,151||61,704|
|Share Based Compensation||12,864||11,848||11,239||7,151||9,015||8,469||15,624||17,794|
|Deferred Income Taxes And Tax Credits||-||-||-||-||-||-||-||-|
|Other Noncash Income Expense||-||-||-||-||-||-||-||-|
|Increase Decrease In Operating Capital|
|Increase Decrease In Mortgage Loans Held For Sale||-||-||-||-||-||-||-||-|
|Increase Decrease In Inventory Real Estate Owned||326,062||148,706||-282,447||315,639||415,312||642,008||497,836||306,896|
|Increase Decrease In Inventory Real Estate Not Owned||-2,805||27,861||-19,727||31,551||43,319||33,027||-34,770||37,728|
|Increase Decrease In Prepaid Deferred Expense And Other Assets||118,265||-111,496||6,212||-2,618||-965||-9,306||2,998||-5,697|
|Increase Decrease In Accounts Payable||-18,554||-6,592||1,113||4,617||13,325||9,314||-89,461||20,099|
|Increase Decrease In Accrued Liabilities||-22,576||-61,843||7,852||9,155||7,949||34,223||26,462||21,541|
|Net Cash Provided By Used In Operating Activities||419,830||-80,958||-322,613||-283,116||-154,216||-362,397||-271,361||322,314|
|Net Cash Provided By Used In Investing Activities|
|Payments To Acquire Interest In Joint Venture||28,600||39,513||14,689||57,458||24,328||10,506||91,453||29,118|
|Proceeds From Dividends Received||3,524||7,640||8,593||14,530||4,763||18,010||19,582||39,735|
|Payments To Acquire Businesses Net Of Cash Acquired||-||-||-||60,752||116,262||33,770||-||-|
|Payments For Proceeds From Other Investing Activities||2,225||1,582||2,217||1,525||8,030||4,754||11,972||7,688|
|Net Cash Provided By Used In Investing Activities||-27,301||-33,455||-8,313||-105,205||-143,857||-31,020||184,674||2,929|
|Net Cash Provided By Used In Financing Activities|
|Proceeds From Repayments Of Restricted Cash Financing Activities||-9,748||-12,843||-1,559||3,347||6,565||-16,762||652||8,873|
|Proceeds From Lines Of Credit||-||-||-||-||-||-||852,700||1,433,200|
|Repayments Of Lines Of Credit||-||-||-||-||-||-||852,700||1,433,200|
|Repayments Of Secured Debt||-||-||-||-||8,334||1,458||2,532||23,228|
|Repayments Of Senior Debt||-||792,389||-||49,603||-||4,971||29,789||280,000|
|Proceeds From Issuance Of Senior Long Term Debt||257,592||977,804||-||253,000||300,000||300,000||-||300,000|
|Payments Of Debt Issuance Costs||8,764||17,215||4,575||11,761||5,316||6,230||1,016||2,669|
|Proceeds From Payments On Mortgage Credit Facilities||22,660||10,651||-16,464||-45,351||-8,708||11,454||-110,469||55,995|
|Payments For Repurchase Of Common Stock||-||-||-||-||-||36,781||22,073||232,520|
|Payments Of Dividends Common Stock||-||-||-||-||-||-||4,851||18,841|
|Proceeds From Payments For Stock Issuance Under Employee Stock Plans||-||-||-||-||-||6,771||1,000||1,330|
|Proceeds From Payments For Other Financing Activities||-||-||-||-||-||-||-222||-200|
|Net Cash Provided By Used In Financing Activities||-422,815||250,225||10,077||324,354||314,809||242,519||60,888||-303,710|
|Cash And Cash Equivalents Period Increase Decrease||-30,286||135,812||-320,849||-63,967||16,736||-150,898||-25,799||21,533|
|Cash And Cash Equivalents At Carrying Value||-||-||410,522||346,555||363,291||212,393||186,594||208,127|
|Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents||-||-||-||-||-||-||-||-|
Peers - Operative Builders (1531)
CCS / Century Communities Inc.
DHI / D.R. Horton, Inc.
HOV / Hovnanian Enterprises, Inc.
KBH / KB Home
MDC / M.D.C. Holdings, Inc.
MHO / M/I Homes, Inc.
MTH / Meritage Homes Corp.
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET